Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
Molecular Pharmaceutics|October 23, 2010
Safety of glucocorticoids in cancer patients treated with oncolytic adenovirusesMaria Rajecki, Mari Raki, Sophie Escutenaire, et al.
Oncoimmunology|May 4, 2016
Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanomaCristian Capasso, Mari Hirvinen, Mariangela Garofalo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 16, 2009
Short-term correction of arginase deficiency in a neonatal murine model with a helper-dependent adenoviral vectorChia-Ling Gau, Robin A Rosenblatt, Vincenzo Cerullo, et al.
Journal of Virology|November 13, 2009
Antiangiogenic arming of an oncolytic vaccinia virus enhances antitumor efficacy in renal cell cancer modelsKilian Guse, Marta Sloniecka, Iulia Diaconu, et al.
Oncoimmunology|June 25, 2024
Loss of β2-integrin function results in metabolic reprogramming of dendritic cells, leading to increased dendritic cell functionality and anti-tumor responsesHeidi Harjunpää, Riku Somermäki, Guillem Saldo Rubio, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 28, 2011
Induction of interferon pathways mediates in vivo resistance to oncolytic adenovirusIlkka Liikanen, Vladia Monsurrò, Laura Ahtiainen, et al.
NPJ Vaccines|August 16, 2025
Proteogenomic approach to immunopeptidomics of ovarian tumors identifies shared peptide vaccine candidatesJacopo Chiaro, Karita Peltonen, Kadri Õunap, et al.
Circulation|May 12, 2004
AKT participates in endothelial dysfunction in hypertensionGuido Iaccarino, Michele Ciccarelli, Daniela Sorriento, et al.
Heliyon|February 6, 2024
Exploring the DNA<sub>2</sub>-PNA heterotriplex formation in targeting the Bcl-2 gene promoter: A structural insight by physico-chemical and microsecond-scale MD investigationAndrea P Falanga, Antonio Lupia, Lorella Tripodi, et al.
Cancer Research|March 8, 2012
Immune response is an important aspect of the antitumor effect produced by a CD40L-encoding oncolytic adenovirusIulia Diaconu, Vincenzo Cerullo, Mari L M Hirvinen, et al.
Pageof 14